<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="2">35578177</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2334</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC infectious diseases</Title>
          <ISOAbbreviation>BMC Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>470</StartPage>
          <MedlinePgn>470</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">470</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07456-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The present study aimed to identify the clinical significance of Mycoplasma pneumoniae (MP)-specific immunoglobulin M (IgM) titer, in addition to a diagnosis of MP infection, in children with MP pneumonia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This study was performed in 155 children hospitalized with MP pneumonia. The clinical features and laboratory and radiographic findings on admission in children with positive or negative MP-specific IgM titers were retrospectively reviewed from the electronic medical records.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of the included children was 6.0 years, and 118 (76.1%) of the children were positive for MP-specific IgM. A longer duration between symptom onset and admission (adjusted odds ratio [aOR] 1.47, 95% confidence interval [CI] 1.24-1.75), longer duration of symptoms during the illness (aOR 1.15, 95% CI 1.02-1.30), and development of extra-pulmonary manifestations (aOR 9.16, 95% CI 1.96-42.81) were significantly associated with a positive MP-specific IgM titer. Serum lactate dehydrogenase levels (aOR 1.00, 95% CI 1.00-1.01) and pneumonic infiltration involving &gt; 50% of the total lung volume on chest radiography (aOR 4.68, 95% CI 1.12-19.55) were associated with positive MP-specific IgM in children with MP pneumonia. A poor response to stepwise treatment for MP pneumonia was more common in children with a positive MP-specific IgM titer than those with a negative MP-specific IgM titer on admission.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A positive MP-specific IgM titer at diagnosis of MP pneumonia may partially suggest an exaggerated immune response with a higher disease burden compared to children with MP pneumonia with a negative MP-specific IgM titer.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Choo</LastName>
            <ForeName>Soojeong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Seo-Hee</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Eun</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea. unelee@daum.net.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Infect Dis</MedlineTA>
        <NlmUniqueID>100968551</NlmUniqueID>
        <ISSNLinking>1471-2334</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="Y">Mycoplasma pneumoniae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Children</Keyword>
        <Keyword MajorTopicYN="N">IgM</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">Pneumonia</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflicts of interest with regard to this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>23</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35578177</ArticleId>
        <ArticleId IdType="pmc">PMC9109195</ArticleId>
        <ArticleId IdType="doi">10.1186/s12879-022-07456-6</ArticleId>
        <ArticleId IdType="pii">10.1186/s12879-022-07456-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, Kim Y, Kim S, Park C, Seo JH, et al.  Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132. doi: 10.1186/s12879-020-4810-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-020-4810-9</ArticleId>
            <ArticleId IdType="pmc">PMC7017508</ArticleId>
            <ArticleId IdType="pubmed">32050912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, et al.  Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. doi: 10.1056/NEJMoa1405870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId>
            <ArticleId IdType="pmc">PMC4697461</ArticleId>
            <ArticleId IdType="pubmed">25714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee E, Young Lee Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med. 2020;175:106209. doi: 10.1016/j.rmed.2020.106209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2020.106209</ArticleId>
            <ArticleId IdType="pubmed">33186845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10(7):535–544. doi: 10.14740/jocmr3421w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14740/jocmr3421w</ArticleId>
            <ArticleId IdType="pmc">PMC5997415</ArticleId>
            <ArticleId IdType="pubmed">29904437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021;21(1):126. doi: 10.1186/s12879-021-05830-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-021-05830-4</ArticleId>
            <ArticleId IdType="pmc">PMC7844890</ArticleId>
            <ArticleId IdType="pubmed">33509121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang M, Wang D, Tong X, Wu Y, Zhang J, Zhang L, Yin Y, Cao Q. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia. BMC Pediatr. 2021;21(1):90. doi: 10.1186/s12887-021-02523-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12887-021-02523-4</ArticleId>
            <ArticleId IdType="pmc">PMC7893926</ArticleId>
            <ArticleId IdType="pubmed">33607971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SC, Youn YS, Rhim JW, Kang JH, Lee KY. Early serologic diagnosis of Mycoplasma pneumoniae pneumonia: an observational study on changes in titers of specific-IgM antibodies and cold agglutinins. Medicine. 2016;95(19):e3605. doi: 10.1097/MD.0000000000003605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000003605</ArticleId>
            <ArticleId IdType="pmc">PMC4902508</ArticleId>
            <ArticleId IdType="pubmed">27175666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon SH, Min IK, Ahn JG. Immunochromatography for the diagnosis of Mycoplasma pneumoniae infection: a systematic review and meta-analysis. PLoS ONE. 2020;15(3):e0230338. doi: 10.1371/journal.pone.0230338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0230338</ArticleId>
            <ArticleId IdType="pmc">PMC7077834</ArticleId>
            <ArticleId IdType="pubmed">32182283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu L, Ye M, Qin X, Liu Y, Lv Z, Zheng R. Diagnostic value of quantitative MP-IgG for Mycoplasma pneumoniae pneumonia in adults. Clin Chim Acta. 2020;503:76–83. doi: 10.1016/j.cca.2020.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cca.2020.01.004</ArticleId>
            <ArticleId IdType="pubmed">31926153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>You SY, Jwa HJ, Yang EA, Kil HR, Lee JH. Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children. Allergy Asthma Immunol Res. 2014;6(1):22–26. doi: 10.4168/aair.2014.6.1.22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4168/aair.2014.6.1.22</ArticleId>
            <ArticleId IdType="pmc">PMC3881395</ArticleId>
            <ArticleId IdType="pubmed">24404389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557–565. doi: 10.1016/j.jmii.2020.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2020.10.002</ArticleId>
            <ArticleId IdType="pubmed">33268306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmitt BH, Sloan LM, Patel R. Real-time PCR detection of Mycoplasma pneumoniae in respiratory specimens. Diagn Microbiol Infect Dis. 2013;77(3):202–205. doi: 10.1016/j.diagmicrobio.2013.07.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2013.07.016</ArticleId>
            <ArticleId IdType="pubmed">24041553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, Weber F, Moll HA, Broekman B, Berger MY, et al.  Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi: 10.1371/journal.pmed.1001444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001444</ArticleId>
            <ArticleId IdType="pmc">PMC3653782</ArticleId>
            <ArticleId IdType="pubmed">23690754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis. 2001;183(4):675–678. doi: 10.1086/318529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/318529</ArticleId>
            <ArticleId IdType="pubmed">11170998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT, Baughman AL, Deutscher M, Fulton JP, Tongren JE, Hicks LA, et al.  Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48(9):1244–1249. doi: 10.1086/597775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/597775</ArticleId>
            <ArticleId IdType="pubmed">19331586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang C, Zhang Q, Du JL, Deng D, Gao YL, Wang CL, Zhao HJ, Guo Q, Fu Z, Tian DY. Correlation between the clinical severity, bacterial load, and inflammatory reaction in children with Mycoplasma pneumoniae pneumonia. Curr Med Sci. 2020;40(5):822–828. doi: 10.1007/s11596-020-2261-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11596-020-2261-6</ArticleId>
            <ArticleId IdType="pmc">PMC7595045</ArticleId>
            <ArticleId IdType="pubmed">33123897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson AC, Bjorkman P, Welinder-Olsson C, Widell A, Persson K. Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis. 2010;10:39. doi: 10.1186/1471-2334-10-39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-10-39</ArticleId>
            <ArticleId IdType="pmc">PMC2837002</ArticleId>
            <ArticleId IdType="pubmed">20184731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Zhao F, Lu J, Xu H, Liu H, Tang X, Yang H, Zhang J, Zhao S. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2019;19(1):1045. doi: 10.1186/s12879-019-4667-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-019-4667-y</ArticleId>
            <ArticleId IdType="pmc">PMC6905005</ArticleId>
            <ArticleId IdType="pubmed">31823740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poddighe D. Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis. Curr Opin Rheumatol. 2018;30(4):380–387. doi: 10.1097/BOR.0000000000000494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000494</ArticleId>
            <ArticleId IdType="pubmed">29432224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang K, Xi W, Yang D, Zheng Y, Zhang Y, Chen Y, Yan C, Tian G, An S, Li X, et al.  Rhinovirus is associated with severe adult community-acquired pneumonia in China. J Thorac Dis. 2017;9(11):4502–4511. doi: 10.21037/jtd.2017.10.107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/jtd.2017.10.107</ArticleId>
            <ArticleId IdType="pmc">PMC5721016</ArticleId>
            <ArticleId IdType="pubmed">29268520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Ling L, Wong SH, Wang MH, Fitzgerald JR, Zou X, Fang S, Liu X, Wang X, Hu W, et al.  Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients. EClinicalMedicine. 2021;37:100955. doi: 10.1016/j.eclinm.2021.100955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eclinm.2021.100955</ArticleId>
            <ArticleId IdType="pmc">PMC8343259</ArticleId>
            <ArticleId IdType="pubmed">34386745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nir-Paz R, Michael-Gayego A, Ron M, Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect. 2006;12(7):685–688. doi: 10.1111/j.1469-0691.2006.01469.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2006.01469.x</ArticleId>
            <ArticleId IdType="pubmed">16774570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang CH, Tsai CK, Tsai TA, Wang SC, Lee YC, Tsai CM, Liu TY, Kuo KC, Chen CC, Yu HR. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan. Pediatr Neonatol. 2021;62(5):536–542. doi: 10.1016/j.pedneo.2021.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pedneo.2021.05.017</ArticleId>
            <ArticleId IdType="pubmed">34147432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A. Macrolide-resistant Mycoplasma pneumoniae infections in children, Ohio, USA. Emerg Infect Dis. 2021;27(6):1588–1597. doi: 10.3201/eid2706.203206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2706.203206</ArticleId>
            <ArticleId IdType="pmc">PMC8153876</ArticleId>
            <ArticleId IdType="pubmed">34013867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YC, Hsu WY, Chang TH. Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia. Emerg Infect Dis. 2020;26(7):1382–1391. doi: 10.3201/eid2607.200017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2607.200017</ArticleId>
            <ArticleId IdType="pmc">PMC7323531</ArticleId>
            <ArticleId IdType="pubmed">32568052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng S, Lin J, Zheng X, Yan L, Zhang Y, Zeng Q, Tian D, Fu Z, Dai J. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2020;55(4):968–974. doi: 10.1002/ppul.24684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.24684</ArticleId>
            <ArticleId IdType="pubmed">32040888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, Kondo E, Teranishi H, Wakabayashi T, Akaike H, et al.  Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J Infect Chemother. 2014;20(4):270–273. doi: 10.1016/j.jiac.2014.01.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiac.2014.01.001</ArticleId>
            <ArticleId IdType="pubmed">24486173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol. 2000;7(5):778–780. doi: 10.1128/CDLI.7.5.778-780.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CDLI.7.5.778-780.2000</ArticleId>
            <ArticleId IdType="pmc">PMC95955</ArticleId>
            <ArticleId IdType="pubmed">10973454</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
